Screener
Emergent Biosolutions EBS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventories, net | 303.6 | 343.4 |
| Prepaid expenses and other current assets | 25.4 | 25.8 |
| Assets held-for-sale | 6.1 | — |
| Total current assets | 666.0 | 662.5 |
| Property, plant and equipment, net | 178.0 | 205.4 |
| Intangible assets, net | 261.8 | 436.5 |
| Other assets | 11.0 | 14.2 |
| Total assets | $1,116.8 | $1,318.6 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's total current assets?
- Emergent Biosolutions (EBS) reported total current assets of $666M in Q2 2026.
- How has Emergent Biosolutions's total current assets changed year-over-year?
- Emergent Biosolutions's total current assets decreased by 7.4% year-over-year, from $719.5M to $666M.
- What is the long-term trend for Emergent Biosolutions's total current assets?
- Over 5 years (2020 to 2025), Emergent Biosolutions's total current assets has grown at a -11.1% compound annual growth rate (CAGR), from $1.2B to $662.5M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Emergent Biosolutions's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude